According to Perrigo's latest financial reports and stock price the company's current Operating Margin is -1.84%. At the end of 2024 the company had an Operating Margin of -1.85%.
Year | Operating Margin | Change |
---|---|---|
2024 | -1.85% | 935.03% |
2023 | -0.18% | -94.29% |
2022 | -3.12% | -149.99% |
2021 | 6.25% | 4231.24% |
2020 | 0.14% | -96.23% |
2019 | 3.82% | -37.73% |
2018 | 6.14% | 8.45% |
2017 | 5.66% | -106.17% |
2016 | -91.81% | -1590.99% |
2015 | 6.16% | -20.61% |
2014 | 7.76% | -54.82% |
2013 | 17.17% | 6.4% |
2012 | 16.14% | -1.35% |
2011 | 16.36% | 20.19% |
2010 | 13.61% | 34.01% |
2009 | 10.15% | -1.29% |
2008 | 10.29% | 67.19% |
2007 | 6.15% | -20.62% |
2006 | 7.75% | -124% |
2005 | -32.29% | -373.67% |
2004 | 11.80% | 14.1% |
2003 | 10.34% | 4.95% |
2002 | 9.85% | 69.29% |
2001 | 5.82% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() United Therapeutics UTHR | 53.48% | -3,006.52% | ๐บ๐ธ USA |
![]() Intercept Pharmaceuticals
ICPT | -59.02% | 3,107.61% | ๐บ๐ธ USA |
![]() Catalent CTLT | -2.05% | 11.41% | ๐บ๐ธ USA |
![]() Endo International
ENDPQ | -129.15% | 6,919.02% | ๐ฎ๐ช Ireland |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.